| Feb 9, 2024 |
Feb 13, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
42.5
|
-3,656
|
-7.53%
|
✗
|
$105.3K |
| Feb 2, 2024 |
Feb 5, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
37.5
|
-209
|
-0.55%
|
✗
|
$6K |
| Jan 26, 2024 |
Jan 29, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-26,017
|
-40.66%
|
✗
|
$660.4K |
| Jan 24, 2024 |
Jan 26, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-11,900
|
-7.01%
|
✗
|
$297.6K |
| Jan 22, 2024 |
Jan 24, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-35,066
|
-16.22%
|
✗
|
$795.2K |
| Jan 6, 2024 |
Jan 9, 2024 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
42.5
|
-4,147
|
-9.85%
|
✗
|
$84.6K |
| Feb 9, 2023 |
Feb 13, 2023 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-2,956
|
-10.52%
|
✗
|
$12.3K |
| Feb 28, 2022 |
Mar 2, 2022 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-1,130
|
-6.75%
|
✗
|
$11.2K |
| Feb 9, 2022 |
Feb 11, 2022 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-1,473
|
-10.45%
|
✗
|
$14.9K |
| Feb 28, 2021 |
Mar 2, 2021 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-1,702
|
-18.74%
|
✗
|
$18.4K |
| Jun 30, 2020 |
Jul 2, 2020 |
EyePoint Pharmaceuticals, Inc.
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-14,060
|
-34.25%
|
✗
|
$10.6K |